scorecardresearch
Add as a preferred source on Google
Thursday, December 4, 2025
TopicCadila Healthcare

Topic: Cadila Healthcare

Cadila looks to double its vaccine production as India battles to contain second Covid wave

The Indian drugmaker expects regulatory approval for its vaccine against Covid-19 by June. Efficacy readings from its last stage of clinical trials are expected in May.

Cadila to boost Covid vaccine production capacity by 70% if it passes human trials

Cadila is looking to hire contract manufacturers for additional 50-70 million doses of its vaccine, on top of 100 million that will come from its own capacity.

Kraft Heinz to sell some of its Indian businesses to Zydus for Rs 46 billion

Kraft to sell Complan, Glucon D & Nycil, among others to Zydus Wellness, in a deal estimated to be worth $625 million.

On Camera

Sanchar Saathi app U-turn is a rare victory for middle-class Indians against Modi govt

The Sanchar Saathi app saga's message to the critics of Modi government is: protest loudly because it is possible to get this administration to reverse its policy.

India’s Russian oil imports are showing up in cryptic new places. The crude map stands redrawn

December oil imports from Russia may drop nearly 50%, but Indian buyers already shifting to non-designated Russian entities and opaque trading channels to keep Russian oil flowing.

From nuclear cooperation to defence, trade to oil, what is expected from Putin’s two-day India visit

New Delhi is interested in firming up bilateral agreements for increased trade, mobility, upgrade of Su-30 MKI fighters and the increased range of BrahMos supersonic missiles.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.